Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Switzerland
Biotech
Vaderis' $152M to fund ph. 3 trial in rare blood vessel disorder
The Basel-based biotech launched the late-stage study to evaluate engasertib in patients with hereditary hemorrhagic telangiectasia.
Marissa Russo
Aug 11, 2026 7:00am
Herantis taps Indivi for digital biomarker tech in new trial
May 19, 2026 7:45am
Private Swiss biotechs hit record funding in 2025
May 4, 2026 10:00pm
Is Basel the next Boston? The Swiss biotech hub raising its game
Aug 8, 2025 9:50am
Ypsomed sells diabetes business to focus on GLP-1 self-injectors
Apr 23, 2025 6:20am
Idorsia's Tryvio sale behind schedule, but layoffs on track
Dec 20, 2024 4:42am
